WHO ICTRP trial
Dissolving the glue in glue ear: Assessment of the efficacy of the use of…
ACTRN12623000504617 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12623000504617 |
|---|---|
| Public title | Dissolving the glue in glue ear: Assessment of the efficacy of the use of Dornase alfa as an adjunct therapy to ventilation tube insertion. |
| Scientific title | Dissolving the glue in glue ear: Assessment of the efficacy of the use of Dornase alfa as an adjunct therapy to ventilation tube insertion. |
| Primary sponsor | Telethon Kids Institute |
| Secondary sponsors | University of Western Australia |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 / Phase 2 |
| Countries | Australia |
| Conditions | otitis media; otitis media;Ear - Other ear disorders |
| Interventions | Children will act as their own internal control. Ears will be individually randomised for each child to receive a single application of 1 ml of Dornase alfa (Pulmozyme®, Genentech) immediately prior to ventilation tube insertion or 1 ml… |
| Registration date | May 17, 2023 |
| Target size | 60 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: